ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $537,400 | -24.6% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $713,200 | +47.8% | 20,000 | +5.3% | 0.00% | 0.0% |
| Q1 2023 | $482,600 | -37.4% | 19,000 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $770,640 | +22.7% | 19,000 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $628,000 | -6.1% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $669,000 | -23.5% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $874,000 | -30.6% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,260,000 | +6.2% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,186,000 | -24.7% | 19,000 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $1,574,000 | -5.1% | 19,000 | -24.0% | 0.00% | 0.0% |
| Q1 2021 | $1,658,000 | -13.6% | 25,000 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $1,918,000 | +78.3% | 25,000 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $1,076,000 | -0.4% | 25,000 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $1,080,000 | +134.8% | 25,000 | +56.2% | 0.00% | +50.0% |
| Q1 2020 | $460,000 | -54.7% | 16,000 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $1,015,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |